SFA
RCKT icon

Sequoia Financial Advisors’s Rocket Pharmaceuticals RCKT Stock Holding History

Sequoia Financial Advisors’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.4K Sell
17,653
-2,696
-13% -$8.96K ﹤0.01% 2117
2026
Q1 		$72.8K Buy
20,349
+8,298
+69% +$33K ﹤0.01% 1876
2025
Q4 		$42.3K Buy
+12,051
New +$41.3K ﹤0.01% 1902

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Sequoia Financial Advisors's RCKT Position: Q2 2026 in Review

Sequoia Financial Advisors reduced its Rocket Pharmaceuticals (RCKT) stake by 13% in Q2 2026, selling an estimated $8.96K and leaving 17,653 shares worth $60.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2117.

Sequoia Financial Advisors first reported a position in RCKT in Q4 2025 and has held it in 3 quarters since. The position peaked at $72.8K in Q1 2026. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Sequoia Financial Advisors held 17,653 shares of Rocket Pharmaceuticals worth $60.4K as of Q2 2026.
  • Sequoia Financial Advisors sold 2,696 Rocket Pharmaceuticals shares in Q2 2026, an estimated $8.96K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #2117 holding.
  • Sequoia Financial Advisors first reported a position in Rocket Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Sequoia Financial Advisors's Rocket Pharmaceuticals position peaked at $72.8K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.